Sleep outcomes following eszopiclone discontinuation in patients with primary insomnia and insomnia co-existing with major depressive disorder or generalized anxiety disorder

被引：0
|
作者：
Krystal, A.
Fava, M.
Pollack, M.
Rubens, R.
Schaefer, K.
Amato, D.
Roth, T.
机构：
[1] Duke Univ, Durham, NC 27706 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Sepracor Inc, Marlborough, MA USA
来源：
SLEEP | 2007年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
720
引用
收藏
页码：A245 / A245
页数：1
相关论文
共 50 条
  • [31] Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder
    Shigetsura, Yuki
    Imai, Satoshi
    Endo, Hiroki
    Shimizu, Yumi
    Ueda, Keita
    Murai, Toshiya
    Itohara, Kotaro
    Nakagawa, Shunsaku
    Yonezawa, Atsushi
    Ikemi, Yasuaki
    Fukatsu, Sachio
    Kitada, Noriaki
    Terada, Tomohiro
    Nakagawa, Takayuki
    Matsubara, Kazuo
    [J]. CLINICAL NEUROPHARMACOLOGY, 2022, 45 (03) : 52 - 60
  • [32] Validation of the sleep impact scale in patients with major depressive disorder and insomnia
    Lasch, Kathryn
    Joish, Vijay N.
    Zhu, Yueping
    Rosa, Kathleen
    Qiu, Chunfu
    Crawford, Bruce
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (07) : 1699 - 1710
  • [33] Comparing primary insomnia to the insomnia occurring in major depression and general anxiety disorder
    Sun, Qiaoling
    Tan, Liwen
    [J]. PSYCHIATRY RESEARCH, 2019, 282
  • [34] Anxiety and insomnia as correlates of major depressive disorder with mixed features
    Oneri, A.
    Crapanzano, C.
    Amendola, C.
    Bolognesi, S.
    Goracci, A.
    Fagiolini, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S436 - S437
  • [35] PREVALENCE OF INSOMNIA AND IMPACT ON QUALITY OF SLEEP IN MAJOR DEPRESSIVE DISORDER
    Vuthandam, Tanmayee
    Reddy, K. Ashok
    Pratheek, Vijay Raj
    Ganta, Akhila
    [J]. INDIAN JOURNAL OF PSYCHIATRY, 2023, 65 : S108 - S108
  • [36] PREVALENCE OF INSOMNIA AND IMPACT ON QUALITY OF SLEEP IN MAJOR DEPRESSIVE DISORDER
    Vuthandam, Tanmayee
    Reddy, Ashok
    Pratheek, Vijay Raj
    Ganta, Akhila
    [J]. INDIAN JOURNAL OF PSYCHIATRY, 2023, 65 : S108 - S108
  • [37] ECONOMIC OUTCOMES OF CO-TREATMENT OF INSOMNIA AND MAJOR DEPRESSIVE DISORDER (MDD) WITH ESZOPICLONE AND FLUOXETINE VERSUS FLUOXETINE TREATMENT ALONE
    Snedecor, S. J.
    Botteman, M. F.
    Schaefer, K.
    Sarocco, P.
    Barry, N.
    Pickard, A. S.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A586 - A586
  • [38] Pharmacological treatment for insomnia in patients with major depressive disorder
    Brietzke, Elisa
    Vazquez, Gustavo H.
    Kang, Melody J. Y.
    Soares, Claudio N.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (11) : 1341 - 1349
  • [39] DAYTIME INSOMNIA SYMPTOMS NEGATIVELY PREDICT ANHEDONIA IN PATIENTS WITH COMORBID MAJOR DEPRESSIVE DISORDER AND INSOMNIA DISORDER
    Osorno, R. A.
    Kaplan, K.
    Krystal, A.
    Buysse, D.
    Edinger, J.
    Manber, R.
    [J]. SLEEP, 2018, 41 : A361 - A362
  • [40] Subjective sleep characteristics in primary insomnia versus insomnia with comorbid anxiety or mood disorder
    Merijn van de Laar
    Dirk Pevernagie
    Petra van Mierlo
    Sebastiaan Overeem
    [J]. Sleep and Biological Rhythms, 2015, 13 : 41 - 48
12345